Antiretroviral Pharmacology Training in Resource Poor Countries

资源匮乏国家的抗逆转录病毒药理学培训

基本信息

  • 批准号:
    7918885
  • 负责人:
  • 金额:
    $ 31.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-04-08 至 2014-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This is a revised AITRP proposal for a postgraduate training initiative with an emphasis on HIV/AIDS clinical pharmacology between the University at Buffalo (UB) and the University of Zimbabwe (UZ). The program faculty at both institutions are experienced investigators that will contribute mentored training to UZ students who, in turn, will contribute clinical pharmacology expertise to multidisciplinary teams to achieve the HIV/AIDS research goals for Zimbabwe. The program is designed for AITRP trainees to benefit from mentored interactions with faculty and health professionals with established clinical/translational and laboratory research environments. The AITRP infrastructure has been broadened to include formalized collaboration with NIAID-funded international, multidisciplinary research networks in Zimbabwe, coordinated through the UZ Clinical Trials Site, as well as other US-supported and Zimbabwe-based research programs. This approach will provide opportunities for AITRP trainees to develop their research career during the AITRP and then continue in a collaborative, mentored environment after the training period. This revised application includes a focused didactic curriculum for postgraduate trainees and an integrated research project experience that includes on-site training at UB and UZ. The AITRP will focus on a group of highly trained individuals who will then pursue their research programs within the multidisciplinary environment that is present at UZ with continued mentoring and career development. Strong institutional support for the proposed AITRP is evident through participation of faculty and administrative leaders at UZ in recognition of the need to support the development of future researchers to address the HIV/AIDS epidemic in Zimbabwe. PUBLIC HEALTH RELEVANCE: As the HIV/AIDS epidemic has continued to impact on developing countries, the need for training in HIV/AIDS clinical Pharmacology has also expanded in scope. Our AITRP meets these needs by providing a mechanism for multi-disciplinary training to conduct HIV/AIDS treatment research and achieve the goals that Zimbabwe has established for optimizing antiretroviral therapy and expanding its pool of clinician scientists.
描述(由申请人提供):这是针对布法罗大学 (UB) 和津巴布韦大学 (UZ) 之间的研究生培训计划的修订版 AITRP 提案,重点是艾滋病毒/艾滋病临床药理学。两个机构的项目教职人员都是经验丰富的研究人员,他们将为乌兹别克斯坦大学的学生提供指导培训,而学生反过来又将为多学科团队贡献临床药理学专业知识,以实现津巴布韦的艾滋病毒/艾滋病研究目标。该计划专为 AITRP 学员设计,让他们在已建立的临床/转化和实验室研究环境下,与教师和卫生专业人员进行指导性互动,从中受益。 AITRP 基础设施已扩大到包括与 NIAID 资助的津巴布韦国际多学科研究网络的正式合作,通过 UZ 临床试验站点以及其他美国支持和津巴布韦的研究项目进行协调。这种方法将为 AITRP 学员提供在 AITRP 期间发展其研究职业的机会,然后在培训期结束后在协作、指导的环境中继续发展。修订后的应用程序包括针对研究生学员的重点教学课程和综合研究项目经验,其中包括在布法罗大学和乌兹别克斯坦大学的现场培训。 AITRP 将重点关注一群训练有素的个人,他们将在乌兹别克斯坦大学的多学科环境中开展研究项目,并得到持续的指导和职业发展。乌兹别克斯坦大学教师和行政领导的参与体现了对拟议的 AITRP 的强有力的机构支持,因为他们认识到需要支持未来研究人员的发展,以解决津巴布韦的艾滋病毒/艾滋病流行问题。公共卫生相关性:随着艾滋病毒/艾滋病流行继续影响发展中国家,艾滋病毒/艾滋病临床药理学培训的需求范围也在扩大。我们的 AITRP 通过提供多学科培训机制来满足这些需求,以开展艾滋病毒/艾滋病治疗研究,并实现津巴布韦为优化抗逆转录病毒治疗和扩大临床科学家库而制定的目标。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Gene D. Morse其他文献

Clinical Pharmacokinetics of Non-Nucleoside Reverse Transcriptase Inhibitors
  • DOI:
    10.2165/00003088-200140120-00002
  • 发表时间:
    2001-01-01
  • 期刊:
  • 影响因子:
    4.000
  • 作者:
    Patrick F. Smith;Robert DiCenzo;Gene D. Morse
  • 通讯作者:
    Gene D. Morse
Compendial testing of antiretroviral drug reference standards for metrologic traceability: Bictegravir and cabotegravir
  • DOI:
    10.1007/s00769-025-01634-0
  • 发表时间:
    2025-04-07
  • 期刊:
  • 影响因子:
    1.000
  • 作者:
    Troy D. Wood;Richard W. Browne;Erin R. Tiede;Connor E. Gould;Diala Ghazal;Robin DiFrancesco;Gene D. Morse
  • 通讯作者:
    Gene D. Morse
Medical and Pharmacy Students’ Awareness, Knowledge, and Attitudes Toward Injectable HIV Pre-Exposure Prophylaxis (PrEP)
  • DOI:
    10.1007/s10900-025-01479-1
  • 发表时间:
    2025-05-21
  • 期刊:
  • 影响因子:
    2.200
  • 作者:
    Jacob Bleasdale;Amy Hequembourg;Gene D. Morse;Sarahmona M. Przybyla
  • 通讯作者:
    Sarahmona M. Przybyla
Mycobacterium Tuberculosis and Interactions with the Host Immune System: Opportunities for Nanoparticle Based Immunotherapeutics and Vaccines
  • DOI:
    10.1007/s11095-018-2528-9
  • 发表时间:
    2018-11-08
  • 期刊:
  • 影响因子:
    4.300
  • 作者:
    Raymonde B. Bekale;Su-Mari Du Plessis;Nai-Jen Hsu;Jyoti R. Sharma;Samantha L. Sampson;Muazzam Jacobs;Mervin Meyer;Gene D. Morse;Admire Dube
  • 通讯作者:
    Admire Dube
Tenofovir-associated kidney disease in Africans: a systematic review
  • DOI:
    10.1186/s12981-019-0227-1
  • 发表时间:
    2019-06-06
  • 期刊:
  • 影响因子:
    2.500
  • 作者:
    Takudzwa J. Mtisi;Chiratidzo E. Ndhlovu;Chiedza C. Maponga;Gene D. Morse
  • 通讯作者:
    Gene D. Morse

Gene D. Morse的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Gene D. Morse', 18)}}的其他基金

HIV Research Training Program
艾滋病毒研究培训计划
  • 批准号:
    9889198
  • 财政年份:
    2016
  • 资助金额:
    $ 31.41万
  • 项目类别:
CLINICAL PHARMACOLOGY QUALITY ASSURANCE AND QUALITY CONTROL
临床药理学质量保证和质量控制
  • 批准号:
    8089738
  • 财政年份:
    2010
  • 资助金额:
    $ 31.41万
  • 项目类别:
Antiretroviral Pharmacology Training in Resource Poor Countries
资源匮乏国家的抗逆转录病毒药理学培训
  • 批准号:
    7680562
  • 财政年份:
    2009
  • 资助金额:
    $ 31.41万
  • 项目类别:
Antiretroviral Pharmacology Training in Resource Poor Countries
资源匮乏国家的抗逆转录病毒药理学培训
  • 批准号:
    8049690
  • 财政年份:
    2009
  • 资助金额:
    $ 31.41万
  • 项目类别:
Antiretroviral Pharmacology Training in Resource Poor Countries
资源匮乏国家的抗逆转录病毒药理学培训
  • 批准号:
    7908275
  • 财政年份:
    2009
  • 资助金额:
    $ 31.41万
  • 项目类别:
Antiretroviral Pharmacology Training in Resource Poor Countries
资源匮乏国家的抗逆转录病毒药理学培训
  • 批准号:
    8248741
  • 财政年份:
    2009
  • 资助金额:
    $ 31.41万
  • 项目类别:
Antiretroviral Pharmacology Training in Resource Poor Countries
资源匮乏国家的抗逆转录病毒药理学培训
  • 批准号:
    8458097
  • 财政年份:
    2009
  • 资助金额:
    $ 31.41万
  • 项目类别:
CLINICAL PHARMACOLOGY QUALITY ASSURANCE AND QUALITY CONTROL
临床药理学质量保证和质量控制
  • 批准号:
    7891925
  • 财政年份:
    2008
  • 资助金额:
    $ 31.41万
  • 项目类别:
AMPRENAVIR AND EFAVIRENZ PHARMACOKINETICS BEFORE AND AFTER THE ADDITION OF
安普那韦和依非韦伦添加前后的药代动力学
  • 批准号:
    7355259
  • 财政年份:
    2006
  • 资助金额:
    $ 31.41万
  • 项目类别:
TDM & Drug Interactions in HIVinfected Substance Abusers
时分复用
  • 批准号:
    6759387
  • 财政年份:
    2003
  • 资助金额:
    $ 31.41万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了